Which pricing strategy did Kary Mullis' company initially use when introducing the revolutionary PCR (Polymerase Chain Reaction) technology to the scientific market in the 1980s?

The commercialization of scientific breakthroughs involves complex pricing strategies that balance research costs, market demand, and ethical considerations. Major research institutions and biotech companies must carefully consider how to price their innovations to recover R&D investments while ensuring accessibility. This poll tests your knowledge of a famous pricing strategy used for a revolutionary scientific product that changed laboratory research forever.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Premium pricing with patent licensing - charging high initial fees but offering tiered licensing agreements for academic vs. commercial use
Freemium model - providing basic PCR equipment for free but charging for specialized reagents and advanced applications
Cost-plus pricing - calculating manufacturing costs plus a standard percentage markup regardless of market demand
Penetration pricing - initially selling below market value to rapidly establish the technology as the industry standard